Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer
2013 · Annals of Oncology · 67 citations
https://doi.org/10.1093/annonc/mdt274
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
67
Citations
1
h-index
1
i10-index
Sang-Jun Im is an academic researcher from Seoul National University Hospital. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Legal and Regulatory Analysis & Linguistic, Cultural, and Literary Studies. The author has an h-index of 1, co-authored 4 publications.
Click to start Chat